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1-Year Results of a Multicenter
The current study was designed to compare the outcomes of the heparin-bonded endograft with the femoropopliteal bypass, including quality of life (QoL) and patency rates.
METHODS
The design was a multicenter prospective randomized controlled trial comparing heparin-bonded 
RCT Comparing Endoluminal and Surgical Bypass
questionnaires were completed by the patients and help from a nurse was provided when needed.
The inclusion and exclusion criteria have been described previously (10) . were required (alpha 5%, power 80%). For a noninferiority trial with regard to 1-year patency, with an effect size of 90% and a margin of 10%, 111 patients per group would be needed (alpha 5%, power 80%). The effect size of 90% refers to an estimated primary patency rate at 1 year in the surgical control arm.
To determine which variables followed the normal distribution, each was tested with the Kolmogorov-Smirnov test. Data were analyzed based on an intention-to-treat principle, but additional perprotocol analyses were performed for patency.
FIGURE 1 Inclusion Flow Chart
Among the 125 treated patients, 63 were randomized in the endoluminal group and 62 were randomized in the surgical group, of which 42
were treated with a venous conduit. ITT ¼ intention to treat; PP ¼ per protocol.
Reijnen et al. Table 1 ; there were no significant differences between groups at baseline. In both groups the proportion of patients treated for IC and CLI were similar, as was baseline ABI and the presence of ulcerations.
The anatomical details are shown in Table 2 . The vast majority of patients were treated for TASC II D lesions without differences between groups except for larger diameter of the popliteal artery and a higher proportion of flush occlusions in the surgical group.
At baseline both groups showed equal scores in all domains of the SF-36, except for a worse "mental health" domain score in the endoluminal group compared with the surgical group Table 3 ) and a higher score for "health change" in the endoluminal group compared with the surgical group. No differences in the separate domains of the WIQ or total WIQ score were observed between groups in patients with IC at baseline ( Table 4) . Values are mean AE SD or %.
ASA ¼ American Society of Anesthesiologists. Values are % or mean AE SD.
TASC ¼ TransAtlantic Inter-Society Consensus.
Reijnen et al. MORBIDITY AND MORTALITY. The total number of complications ( Table 5 ) was significantly higher in the surgical bypass group compared with the endoluminal group, as was the 30-day morbidity rate. The vast majority of complications were minor and resolved without treatment. In both groups 5 complications resulted in a procedure-related serious adverse event.
In the endoluminal group 2 dislocated closure devices resulted in reintervention and 2 patients were re-admitted for wound infections (treated with intravenous antibiotics) and another patient's hospitalization was prolonged because of pancreatitis. In the surgical group these included 1 patient in whom a reintervention for occlusion was performed, 1 patient with reintervention for occlusion and a deep Values are %. *p < 0.05 between study groups at the different time points.
WIQ ¼ Walking Impairment Questionnaire.
Reijnen et al. Values are n, n (%), or median (range).
SAE ¼ serious adverse event.
FIGURE 2 Evolution of the Rutherford Category
Bar chart presenting the Rutherford stages at baseline as well as 1-month and 12-month follow-up. E ¼ endoluminal bypass; S ¼ surgical bypass.
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Reijnen et al. Reijnen et al. according to PP analysis. Abbreviations as in Figure 1 . found (14) . The morbidity rate seems to be higher in the current study as compared with previous literature, reporting a morbidity rate of 37% after bypass surgery (15); the authors, however, clearly demonstrated that morbidity was inconsistently reported and definitions were often lacking, which likely caused an underestimation of the true incidence of complications after bypass surgery. We are aware that we report complications more extensively than most reports.
We did not observe differences in patency rates between groups up to 1-year follow-up. As the study was terminated before reaching the sample size for the primary patency endpoint, due to a low inclusion rate, noninferiority cannot be claimed on this endpoint. Nevertheless, with the available data there are no indications that 1 of the arms would become superior over the other with a larger sample size. The primary patency rate was lower than anticipated, Reijnen et al. study, which has been designed to compare the endovascular strategy, using drug-eluting stents, and Reijnen et al.
N O V E M B E R 2 7 , 2 0 1 7 : 2 3 2 0 -3 1 prosthetic bypass surgery in long and more complex superficial femoral artery lesions (NCT01952457).
STUDY LIMITATIONS. First, the study was terminated after achieving the sample size necessary for the designed power for the expected QoL, but before reaching that necessary to determine designed noninferiority in patency outcomes. The enrollment rate during the study period was lower than anticipated and, given the required sample size for the patency endpoint, the projected enrollment period would become unacceptably long. Selection bias might have occurred. Additionally, the proportion lost to followup was relatively high, reflecting the frailty of this study population. Although the study was performed in 6 sites, the vast majority of patients were included in only few of them. This suggests that patients, meeting the inclusion criteria, were likely to be missed. Although the power for the primary endpoint health status was achieved, the absolute numbers in each group were limited, rendering the subgroup analyses less reliable. Screen failures were not documented throughout the inclusion period.
CONCLUSIONS
We have shown that heparin-bonded endoluminal bypass when compared with the femoropopliteal bypass, is related to less morbidity, a faster recovery, and improvement in QoL, whereas no differences in patency were observed. Although these results are 
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